Biology & biomedicine Technological offers
A biomarker signature for predicting response to cancer immunotherapy
- Details
- Category: Technological offers
-
05 May 2022
The CSIC has developed, together with other institutions, a method to personalise therapeutic strategies combined with immune checkpoint inhibitors (ICIs) in cancer patients. It is based on 10 biomarkers, and facilitates the optimisation of therapeutic strategies for various types of tumours.
Patented molecules that counteract the effect of the most common anticoagulant drug
- Details
- Category: Technological offers
-
16 Mar 2022
Researchers at IQAC-CSIC have successfully tested molecules that reverse the effect of the anticoagulant heparin, used to treat patients at risk of thrombosis. These new molecules have been patented. Patients treated with heparin may need to block its effect during surgery. The only drug available nowadays has a high molecular weight and may have associated side effects.
DNA probes for the fast detection of SARS-CoV2 and influenza virus
- Details
- Category: Technological offers
-
01 Mar 2022
Scientists from the CSIC, the University of Barcelona and the CIBER network laboratory have developed DNA probes for the fast detection of respiratory disease viruses, including SARS-CoV2 and influenza. The technology is available for further development through agreements with industry partners.
Miniaturized device for electrical stimulation of cell cultures
- Details
- Category: Technological offers
-
02 Mar 2022
The use of electrical stimulation in medical research is growing rapidly for its effects on cell regeneration. The CSIC, the Autonomous University of Madrid and the University of Florida have developed a miniaturised device for in vitro electrical stimulation of cells and tissues. The technology is available for further development and commercialization.
Folding paper device for an early detection of infections in chronic wounds
- Details
- Category: Technological offers
-
25 Nov 2021
Scientists from the CSIC and from the UPC university have developed a ‘point-of-care’ device for an early detection of infections by means of analysing body fluids such as saliva or exudates from chronic wounds.
